Company: SWKH
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001628280-25-013989
Chunk: 116

Company: SWK Holdings Corp
Filing Date: 2025-03-20
Form: 10-K
Item: Item 1B
Chunk 116
---
 customers. Segment performance is evaluated based on several factors, including income (loss) from continuing operations before income taxes. Management uses this measure of profit (loss) to evaluate segment performance because the Company believes this measure is indicative of performance trends and the overall earnings potential of each segment. The Company does not report assets by reportable segment, as this metric is not used by the Company's CEO in assessing performance or allocating resources to the segments. As of December 31, 2024, Enteris is classified as held for sale (Pharmaceutical Development segment shown below) - see Note 7 for further details.

65

The following tables present financial information for the Company’s reportable segments for the periods indicated (in thousands):            Year Ended December 31, 2024Finance ReceivablesPharmaceutical Development and OtherHolding Company and OtherConsolidatedRevenue$40,787 $3,616 $— $44,403 Other revenue553 31 — 584 Provision for credit losses12,756 — — 12,756 Loss on impairment of intangible assets— 5,771 — 5,771 Interest expense1,078 8 3,599 4,685 Pharmaceutical manufacturing, research and development— 2,203 — 2,203 Change in fair value of acquisition-related contingent consideration— (4,900)— (4,900)Depreciation and amortization expense— 1,316 83 1,399 General and administrative expense449 2,967 8,071 11,487 Other income (expense), net7,194 — (408)6,786 Income tax expense— — 4,884 4,884 Net income (loss)34,251 (3,718)(17,045)13,488 Year Ended December 31, 2023Finance ReceivablesPharmaceutical Development and OtherHolding Company and OtherConsolidatedRevenue$36,346 $1,202 $— $37,548 Other revenue204 2 6 212 Provision for credit losses1,912 — — 1,912 Impairment of goodwill— 8,404 — 8,404 Interest expense982 3 864 1,849 Pharmaceutical manufacturing, research and development expense— 3,436 —